GENE ONLINE|News &
Opinion
Blog

KRAS
Study Advocates Cautious Application of CRISPR in Designing Therapeutics
2021-11-22
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
We Have a Winner! Amgen Grabs First FDA Nod in the Race for Undruggable KRAS
2021-05-30
R&D
Targeting KRAS Mutants: Advances in Drugging the “Undruggable”
2021-04-19
Investors Bet $120 Million on Ikena Oncology’s Cancer Therapies
2021-01-06
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
R&D
Amgen’s KRAS Inhibitor Registers Long-Lasting Performance in Solid Tumors
2020-09-27
New Frontiers in Therapeutics
2020-07-25Partner
AACR 2020: Targeting the KRAS Pathway – Old Protein, New Approaches
2020-04-30
Amgen’s Efficacy of AMG 510 to KRAS G12C Mutant Critical for Future Directions and Business Investments
2019-10-02
LATEST
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
Exosomes: The Small Couriers Moving Beyond Traditional Drug Delivery
2025-04-17
Trump Administration’s CDC Layoffs Shutter STD Lab, Sending Ripples Through Biotech and Global Health
2025-04-17
Fake Ozempic Floods Market as FDA Warns Patients to Check Authenticity of Prescriptions
2025-04-16
NIH Facing $20 Billion Budget Cut and Potential Consolidation in 2026
2025-04-16
Trump Administration Budget Proposal Includes $20 Billion Cut to NIH by 2026 and Agency Reorganization
2025-04-16
Robert F. Kennedy Jr.’s Proposed Budget Prioritizes Public Health, Environmental Protection, and Healthcare Reform
2025-04-16
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
Scroll to Top